Latest debt-to-equity ratio for Iterum Therapeutics Plc: -0.0 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.00
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
As of the most recent data, ITRM shows a debt-to-equity ratio of -0.0. That is below the Healthcare sector average of 0.34. Scroll down for historical charts and peer comparison views.
The Healthcare sector average debt-to-equity ratio is about 0.34. Iterum Therapeutics Plc is at -0.0, which is lower that average. That is roughly 101.0% below the sector mean. Use the comparison chart on this page to see how ITRM stacks up against individual peers as well.
Investors watch ITRM's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Iterum Therapeutics Plc's latest reading is -0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this debt-to-equity ratio page, Stockcircle has Iterum Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently -0.0) with ownership activity and broader fundamentals.
The Healthcare average debt-to-equity ratio is about 0.34, while ITRM is at -0.0. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.